Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathwayMingjing Shen, Yongbing Chen|Journal of Experimental & Clinical Cancer Research|2019Cited by 221
A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With CancerGuo‐Tian Ruan, Hanping Shi, Kunhua Wang et al.|Frontiers in Endocrinology|2022Cited by 161
M2 macrophage-derived exosomal long non-coding RNA AGAP2-AS1 enhances radiotherapy immunity in lung cancer by reducing microRNA-296 and elevating NOTCH2Fuquan Zhang, Yongbing Chen|Cell Death and Disease|2021Cited by 106
Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling PathwayDonglai Chen, Yongbing Chen, Fuquan Zhang et al.|Frontiers in Pharmacology|2018Cited by 48
Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancerGuo‐Tian Ruan, Hanping Shi, Hailun Xie et al.|Clinical Nutrition|2022Cited by 31